Clinical Trial Update: Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rovalpituzumab tesirine to topotecan in advanced/metastatic small cell lung cancer with high DLL3 after frontline chemotherapy; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)
• rovalpituzumab tesirine (rovalpituzumab tesirine)

Snippet

Sponsor: AbbVie | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-02-23